Ocean Biological Co., Ltd.

Pre-Disclosure Announcement on the Reduction of Shares by the Consistent Action Person of the Actual Controller

Announcement on participating in the online collective reception day for investors of listed companies in Zhejiang for 2026 and the performance briefing for the year 2025

Announcement on the progress of redeeming part of the idle raised funds for cash management and continuing cash management

Announcement on the Proposed Reappointment of the Audit Institution for 2026

Announcement on Confirming the 2025 Annual Compensation of Directors and Senior Management and the 2026 Annual Compensation Plan

Independent Director 2025 Annual Work Report (Zeng Aimin)

Independent Director 2025 Annual Work Report (Han Qiuyan)

Independent Director 2025 Annual Work Report (Jiang Yan)

Zhejiang Ocean Biotechnology Group Co., Ltd. Internal Control Audit Report Zhonghui Audit Review [2026] No. 7751

2025 Annual Internal Control Self-Assessment Report

Compensation Management System for Directors and Senior Management

Announcement on Changes in Accounting Policies

Zhejiang Dayang Biotechnology Group Co., Ltd. Articles of Association (2026 Revision)

Announcement on Changing Registered Capital, Business Scope, and Revising the Articles of Association

Caitong Securities Co., Ltd. Verification Opinion on the Storage and Use of Raised Funds of Zhejiang Dayang Biotechnology Group Co., Ltd. for 2025

Special Report on the Storage, Management, and Use of Raised Funds for 2025

Announcement on Expected Routine Related Transactions for 2026 and Confirmation of Routine Related Transactions for 2025

Announcement on the Company's Financing from Banks and Guarantees for Subsidiaries

Feasibility Analysis Report on Conducting Financial Derivative Trading Business in 2026

Announcement on Conducting Financial Derivative Trading Business in 2026

Notice of the 2025 Annual Shareholders' Meeting

Resolution Announcement of the 9th Meeting of the 6th Board of Directors

Announcement on the 2025 Profit Distribution and Capital Reserve Transfer to Increase Share Capital Plan and 2026 Mid-Year Profit Distribution Authorization Arrangement

2026 Q1 Report

Zhejiang Dayang Biotechnology Group Co., Ltd. Board Special Explanation on Securities Investment

Zhejiang Dayang Biotechnology Group Co., Ltd. Annual Verification Report on the Storage, Management, and Use of Raised Funds Zhonghui Meeting Verification [2026] 7750

Zhejiang Dayang Biotechnology Group Co., Ltd. Board Audit Committee Report on the Performance Evaluation of the Accounting Firm for 2025 and Supervision Responsibilities

Special Audit Explanation on Non-Operating Fund Occupation and Other Related Fund Transactions of Zhejiang Dayang Biotechnology Group Co., Ltd. Zhonghui Meeting Special [2026] 7749